Hak-Hyun Nam
Founder chez I-SENS, INC.
Fortune : 31 M $ au 31/03/2024
Profil
Hak-Hyun Nam is the founder of i-SENS, Inc. which was founded in 2000.
She is currently a Non-Executive Director at Precision Biosensor, Inc., a Director at I Sense Jiangsu Co., Ltd., and a Director at CoaguSense, Inc. Dr. Nam holds a doctorate degree from Michigan State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
I-SENS, INC.
7,21% | 15/04/2024 | 1 985 000 ( 7,21% ) | 30 M $ | 31/03/2024 |
| 30/06/2023 | 100 000 ( 0,86% ) | 362 488 $ | 31/03/2024 |
Postes actifs de Hak-Hyun Nam
| Sociétés | Poste | Début |
|---|---|---|
| I-SENS, INC. | Founder | 04/05/2000 |
| PRECISION BIOSENSOR, INC. | Director/Board Member | - |
| I Sense Jiangsu Co., Ltd. | Director/Board Member | - |
CoaguSense, Inc.
 CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Director/Board Member | - |
Formation de Hak-Hyun Nam
| Michigan State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| I-SENS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Precision Biosensor, Inc. | |
| I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
